Nexalin Technology, Inc. - NXL

Sector: Healthcare · Industry: Electromedical & Electrotherapeutic Apparatus
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$675K
QoQ value delta ($000)
+$48K (+7.66%)
Implied price effect (QoQ)
-39.05%
Shares
Total shares
1,223,287
QoQ shares delta
+530,700 (+76.63%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (NXL)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 20 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
PEAK6 LLC 265 476,509 0.0%
VANGUARD GROUP INC 99 177,922 0.0%
GEODE CAPITAL MANAGEMENT, LLC 83 150,274 0.0%
RENAISSANCE TECHNOLOGIES LLC 68 122,100 0.0%
Virtu Financial LLC 22 39,408 0.0%
JANE STREET GROUP, LLC 19 35,016 0.0%
STATE STREET CORP 18 32,300 0.0%
FMR LLC 17 31,625 0.0%
CITADEL ADVISORS LLC 17 30,907 0.0%
TWO SIGMA SECURITIES, LLC 16 28,712 0.0%
NORTHERN TRUST CORP 13 24,100 0.0%
Kovack Advisors, Inc. 13 23,325 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10 18,874 0.0%
UBS Group AG 8 15,901 0.0%
LPL Financial LLC 5 10,481 0.0%
Tower Research Capital LLC (TRC) 1 2,338 0.0%
OSAIC HOLDINGS, INC. 1 2,350 0.0%
BANK OF AMERICA CORP /DE/ 0 145 0.0%
Farther Finance Advisors, LLC 0 1,000 0.0%